Multiplex immunofluorescence staining assays demonstrated a 33% increase in the proportion of tumor cells expressing both c-Jun and cleaved caspase 3 (cJun+/CC3+) after treatment with Ixa + Dina (Fig. 6F and G). This evidence concerns the gene CASP3 and neoplasm.